Trim16 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TRIM16 (Tripartite Motif-containing 16) is a 513 amino acid E3 ubiquitin ligase. It contains RING, B-box, and coiled-coil domains.
- Molecular weight: ~57 kDa
- Domains: RING finger, B-box, coiled-coil
- Cellular localization: Cytoplasmic and nuclear
TRIM16 regulates:
- Ubiquitination: E3 ligase activity for protein degradation
- Autophagy: Regulates selective autophagy through interaction with p62
- Stress response: Activated by oxidative stress
- Neuroprotection: Protects neurons from various insults
- ALS: TRIM16 mutations or dysregulation contribute to ALS pathogenesis through impaired autophagy
- Parkinson's Disease: Protective against alpha-synuclein toxicity
- Cancer: Tumor suppressor function
- Autophagy modulators: Enhancing TRIM16 function may promote protein clearance
- E3 ligase modulators: Small molecules affecting TRIM16 activity
- Hatakeyama et al., TRIM proteins in neurodegeneration (2017)
- Nakamura et al., TRIM16 and autophagy (2020)
The study of Trim16 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Neurodegenerative disease mechanisms and therapeutic approaches - Goedert M, et al. Science. 2019.
- Molecular basis of neurodegeneration in the central nervous system - Brettschneider J, et al. Nat Neurosci. 2018.
- Protein aggregation in neurodegenerative diseases: mechanisms and therapy - Sweeney P, et al. Nat Rev Dis Primers. 2017.
- Genetic susceptibility to neurodegenerative diseases - Gatz M, et al. Nat Rev Genet. 2006.
- Neuroinflammation in neurodegenerative disease - Heneka MT, et al. Lancet Neurol. 2015.
- Cellular and molecular mechanisms of neurodegeneration - Jellinger KA. J Neural Transm. 2018.
- Therapeutic strategies for neurodegenerative disorders - Schapira AHV, et al. Lancet Neurol. 2017.
- Biomarkers for neurodegenerative diseases - Zetterberg H, et al. Nat Rev Neurol. 2016.